Rowena Schwartz

2.3k total citations · 1 hit paper
34 papers, 1.7k citations indexed

About

Rowena Schwartz is a scholar working on Oncology, Hematology and Surgery. According to data from OpenAlex, Rowena Schwartz has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Hematology and 5 papers in Surgery. Recurrent topics in Rowena Schwartz's work include Multiple Myeloma Research and Treatments (6 papers), Cancer Treatment and Pharmacology (6 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Rowena Schwartz is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Cancer Treatment and Pharmacology (6 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Rowena Schwartz collaborates with scholars based in United States, Saudi Arabia and Russia. Rowena Schwartz's co-authors include B Freundlich, Petra Feyer, Gary R. Morrow, Mark R. Somerfield, Ethan Basch, Kamakshi V. Rao, Rebecca Clark-Snow, Ann Alexis Prestrud, Mark G. Kris and Gary H. Lyman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rowena Schwartz

33 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

2011 827 citations Ethan Basch, Ann Alexis Prestrud et al. Journal of Clinical Oncology profile →

Peers

Rowena Schwartz

SURGE

ONCOL

PHYSI

HEMAT

PPCH

Bea C. Tanis Netherlands

Kamakshi V. Rao United States

Rolf Richter Germany

George Dranitsaris Canada

A. Gerson Greenburg United States

François Goldwasser France

Christian Noël France

Francesco Ferraù Italy

Karin Jordan Germany

N. Simon Tchekmedyian United States

Bea C. Tanis Netherlands

Rowena Schwartz

280 ×0.4

SURGE

326 ×0.7

ONCOL

321 ×0.8

PHYSI

329 ×1.3

HEMAT

189 ×0.9

PPCH

Citations per year, relative to Rowena Schwartz Rowena Schwartz (= 1×) peers Bea C. Tanis

Countries citing papers authored by Rowena Schwartz

Since Specialization

Citations

This map shows the geographic impact of Rowena Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rowena Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rowena Schwartz more than expected).

Fields of papers citing papers by Rowena Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rowena Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rowena Schwartz. The network helps show where Rowena Schwartz may publish in the future.

Co-authorship network of co-authors of Rowena Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Rowena Schwartz. A scholar is included among the top collaborators of Rowena Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rowena Schwartz. Rowena Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jun, Melissa L. Johnson, Minal Barve, et al.. (2023). Practical Guidance for the Management of Adverse Events in Patients with KRASG12C-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib. The Oncologist. 28(4). 287–296. 10 indexed citations

Michaud, Laura Boehnke, et al.. (2019). Women in oncology pharmacy leadership: A white paper. Journal of Oncology Pharmacy Practice. 26(1). 175–186. 5 indexed citations

Nightingale, Ginah, et al.. (2018). Clinical pharmacology of oncology agents in older adults: A comprehensive review of how chronologic and functional age can influence treatment-related effects. Journal of Geriatric Oncology. 10(1). 4–30. 26 indexed citations

Schwartz, Rowena. (2017). Management of Venous Thromboembolism for Patients With Hematologic Malignancies.. PubMed. 8(3). 297–302. 1 indexed citations

Stricker, Carrie Tompkins, et al.. (2014). Navigating the Seasons of Survivorship in Community Oncology. Clinical journal of oncology nursing. 18(s1). 9–14. 9 indexed citations

Rodgers, George M., Pamela S. Becker, Morey A. Blinder, et al.. (2012). Cancer- and Chemotherapy-Induced Anemia. Journal of the National Comprehensive Cancer Network. 10(5). 628–653. 171 indexed citations

Schwartz, Rowena, et al.. (2012). Integration of survivorship care in community oncology practice.. Journal of Clinical Oncology. 30(34_suppl). 33–33. 4 indexed citations

Basch, Ethan, Ann Alexis Prestrud, Paul J. Hesketh, et al.. (2011). Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. 29(31). 4189–4198. 827 indexed citations breakdown →

Goodin, Susan, et al.. (2011). Safe Handling of Oral Chemotherapeutic Agents in Clinical Practice: Recommendations From an International Pharmacy Panel. Journal of Oncology Practice. 7(1). 7–12. 79 indexed citations

10.

Valgus, John, et al.. (2010). Use of a pharmacist/nurse model for the delivery of supportive care in adult oncology clinics at the University of North Carolina Hospital.. Journal of Clinical Oncology. 28(15_suppl). 9166–9166. 3 indexed citations

11.

Jagannath, Sundar, Ravi Vij, George Somlo, et al.. (2009). A377 Phase II Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (PX-171-003). Clinical Lymphoma & Myeloma. 9. S61–S61. 1 indexed citations

12.

Schwartz, Rowena, et al.. (2008). Current and Emerging Treatments for Multiple Myeloma. Journal of Managed Care Pharmacy. 14(7 Supp A). 12–18. 20 indexed citations

13.

Cook, Richard, et al.. (2008). Recent Advances in the Understanding and Treatment of Multiple Myeloma. Journal of Managed Care Pharmacy. 14(7 Supp A). 1–30. 1 indexed citations

14.

Schwartz, Rowena. (2007). Anemia in patients with cancer: Incidence, causes, impact, management, and use of treatment guidelines and protocols. American Journal of Health-System Pharmacy. 64(3_Supplement_2). S5–S13. 86 indexed citations

15.

Viale, Pamela Hallquist & Rowena Schwartz. (2004). Venous Thromboembolism in Patients With Cancer Part I: Survey of Oncology Nurses' Attitudes and Treatment Practices for Ambulatory Settings. Clinical journal of oncology nursing. 8(5). 455–461. 7 indexed citations

16.

Viale, Pamela Hallquist & Rowena Schwartz. (2004). Venous Thromboembolism in Patients With Cancer Part II: Current Treatment Strategies. Clinical journal of oncology nursing. 8(5). 465–469. 3 indexed citations

17.

Jung, Laura & Rowena Schwartz. (2002). Darbepoetin Alfa. Cancer Practice. 10(6). 327–330. 4 indexed citations

18.

Bender, Catherine M., Roxanne W. McDaniel, Mary Pickett, et al.. (2002). Chemotherapy-Induced Nausea and Vomiting. Clinical journal of oncology nursing. 6(2). 94–102. 69 indexed citations

19.

Rubin, Joshua T., Michael T. Lotze, R. E. Howells, et al.. (1995). Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: Interim results of a phase I trial. Annals of Surgical Oncology. 2(4). 351–359. 2 indexed citations

20.

Lee, Mary, et al.. (1981). Tartrazine-Containing Drugs. Drug Intelligence & Clinical Pharmacy. 15(10). 782–788. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact